RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Caladrius Biosciences Stock and on which exchange is it traded?
The symbol for Caladrius Biosciences is CLBS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Caladrius Biosciences Stock?
Caladrius Biosciences holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Caladrius Biosciences Stock?
Caladrius Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Caladrius Biosciences Stock.

What's the current price of Caladrius Biosciences Stock?
As of the end of day on the 2023-01-27, the price of an Caladrius Biosciences (CLBS) share was $3.55.

What is the 52-week high and low for Caladrius Biosciences Stock?
The 52-week high for Caladrius Biosciences Stock is $9.75 and the 52-week low is $0.402.

What is the market capitalization of Caladrius Biosciences Stock?
As of the 2023-01-27, the market capitalization of Caladrius Biosciences is 3.351M.
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT